Lv2
200 积分 2025-07-20 加入
Mucormycosis
1天前
已关闭
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial
4个月前
已完结
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trial
5个月前
已完结
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study
5个月前
已完结
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management
5个月前
已完结
Therapeutic Applications of Programmed Death Ligand 1 Inhibitors in Small Cell Lung Cancer
5个月前
已完结
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options
5个月前
已完结
Advancing immunotherapy in small cell lung cancer
5个月前
已完结
皖公网安备34019202002308
